The Zambia cholera vaccines market has been witnessing significant growth in recent years. Cholera vaccines help in preventing the contraction and spread of cholera. They provide active immunization against cholera infection. The oral cholera vaccine comes in liquid form and contains weakened yet live cholera bacteria. When swallowed, it helps to build immunity in the intestines that fights against cholera infection. Cholera is an acute diarrheal illness caused by the bacterium Vibrio cholera and is commonly associated with poor sanitation and lack of clean drinking water. Timely administration of cholera vaccines plays a crucial role in managing cholera outbreaks.

The Global Zambia cholera vaccines market is estimated to be valued at US$1.47million in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Zambia cholera vaccines market are Biovac Inc., Valneva SE., EMERGENT, Astellas Pharma Inc, Sanofi, EUBIOLOGICS CO., LTD,Johnson & Johnson Services Inc., Celldex Therapeutics. Growing demand for cholera vaccines is attributed to frequent cholera outbreaks in Zambia. According to WHO, between January to September 2021, over 13,000 cholera cases and 290 cholera related deaths were recorded in Zambia.There is an increase in awareness about cholera immunization which is boosting the adoption of cholera vaccines. Manufacturers are increasingly focusing on global expansion to meet the rising requirement of cholera vaccines in Zambia and other African countries.

Market Drivers

The increasing incidence of Zambia Cholera Vaccines Market Size outbreaks has led to growing demand. Unsafe water supply and lack of proper sanitation facilities remain the key reasons for recurrent cholera outbreaks in the country. According to the WHO, all provinces in Zambia are currently experiencing an active cholera outbreak. Zambia has a high risk of cholera transmission due to inadequate water treatment, lack of access to improved water sources in communities and open defecation. Frequent flooding worsens the risk of cholera due to contamination of water sources. Campaigns by the Zambian government and international health organizations to promote cholera immunization are boosting the adoption of cholera vaccines. Manufacturers are also collaborating with governments to ensure effective supply and access to cholera vaccines to control outbreaks.

Impact of geopolitical situation on Zambia Cholera Vaccines market growth

The Zambia Cholera Vaccines market is witnessing decent growth over the past few years. However, the current geopolitical instability across certain regions is posing challenges to market expansion. The ongoing Russia-Ukraine conflict has severely disrupted global supply chains and inflated commodity prices worldwide. This has made import and export of medical supplies more difficult and costly. Rising tensions between China and Taiwan may also affect the smooth flow of raw materials required for vaccine production. Such geo-economic pressures will negatively impact the availability and affordability of cholera vaccines in Zambia in the coming years.

To counter these challenges, manufacturers will need to diversify their sourcing networks and establish multiple suppliers in different geographies. This can help reduce dependency on key regions and enable cope up even during regional emergencies or trade restrictions. Local production capabilities may also be enhanced through technology transfers and partnerships with domestic players. Governments and aid agencies must ensure adequate funding and logistical support to health departments for continuous vaccine distribution, especially in remote areas affected by conflicts or natural calamities. International cooperation on trade facilitation and humanitarian access will be essential to meet public health goals.

Concentration of Zambia Cholera Vaccines market in key regions

Presently, the Zambian capital Lusaka accounts for over 35% share of the country's cholera vaccines market in terms of value. This is owing to its high population density, strong healthcare infrastructure, and strategic location serving as a major transit hub. The Copperbelt Province generates 25% of total revenues led by urban centers of Ndola and Kitwe with substantial mining and industrial activities. Remote provincial towns near lakes and rivers also contribute significantly to demand as cholera outbreaks frequently occur in such locations with inadequate sanitation facilities. Aid-dependent regions like Western and Eastern Province collectively make up 30% of the market due to recurrent epidemics and humanitarian operations.

Fastest growing region in Zambia Cholera Vaccines market

The Zambia Cholera Vaccines market is poised to witness the fastest value growth in North-Western Province over the forecast period. This is attributed to large development projects underway to improve road and rail connectivity, establish Special Economic Zones, and expand mining and agriculture sectors in the region. Rising migrant population and increased tourism along the Zambia-DR Congo border also contributes to market expansion. Government prioritization of upgrading public health infrastructure in North-Western Province through new treatment centers, training programs for health workers and awareness campaigns will further spur preventive healthcare uptake. Upgrading of vital transport corridors to industrial hubs like Solwezi and Kasempa will additionally bolster vaccine access.

Get more insights on Zambia Cholera Vaccines Market